CNXC vs. ARCT
Compare and contrast key facts about Concentrix Corporation (CNXC) and Arcturus Therapeutics Holdings Inc. (ARCT).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CNXC or ARCT.
Key characteristics
| CNXC | ARCT | |
|---|---|---|
| YTD Return | -39.04% | -13.51% |
| 1Y Return | -30.30% | 2.60% |
| 3Y Return (Ann) | -27.13% | -6.46% |
| Sharpe Ratio | -0.83 | 0.04 |
| Daily Std Dev | 41.25% | 69.14% |
| Max Drawdown | -72.83% | -97.70% |
| Current Drawdown | -70.39% | -84.73% |
Fundamentals
| CNXC | ARCT | |
|---|---|---|
| Market Cap | $3.63B | $714.60M |
| EPS | $4.78 | -$1.12 |
| PE Ratio | 11.51 | 10.30 |
| Revenue (TTM) | $7.88B | $166.80M |
| Gross Profit (TTM) | $2.26B | $62.95M |
| EBITDA (TTM) | $1.24B | -$75.25M |
Correlation
The correlation between CNXC and ARCT is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CNXC vs. ARCT - Performance Comparison
In the year-to-date period, CNXC achieves a -39.04% return, which is significantly lower than ARCT's -13.51% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CNXC vs. ARCT - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Concentrix Corporation (CNXC) and Arcturus Therapeutics Holdings Inc. (ARCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CNXC vs. ARCT - Dividend Comparison
CNXC's dividend yield for the trailing twelve months is around 1.99%, while ARCT has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
CNXC Concentrix Corporation | 1.99% | 1.15% | 0.77% | 0.14% |
ARCT Arcturus Therapeutics Holdings Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CNXC vs. ARCT - Drawdown Comparison
The maximum CNXC drawdown since its inception was -72.83%, smaller than the maximum ARCT drawdown of -97.70%. Use the drawdown chart below to compare losses from any high point for CNXC and ARCT. For additional features, visit the drawdowns tool.
Volatility
CNXC vs. ARCT - Volatility Comparison
The current volatility for Concentrix Corporation (CNXC) is 10.67%, while Arcturus Therapeutics Holdings Inc. (ARCT) has a volatility of 19.92%. This indicates that CNXC experiences smaller price fluctuations and is considered to be less risky than ARCT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CNXC vs. ARCT - Financials Comparison
This section allows you to compare key financial metrics between Concentrix Corporation and Arcturus Therapeutics Holdings Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities